Skip to content
General News, Medical Health Aged Care

Funding disparity disadvantages rural residents

La Trobe University 2 mins read

Rural health researchers at La Trobe University say the funding disparity between rural and metropolitan Australians is “inequitable and unfair” and are calling for greater investment in rural health research.  

Professor Jane Mills, Dean of the La Trobe Rural Health School, co-authored an opinion piece with Dr Leesa Hooker and Dr Fiona Burgemeister 

They say the discrepancy is particularly concerning as rural residents already have poorer health than their urban counterparts 

Professor Mills said new models of health care are need in rural areas to address the inequities in outcomes 

“We already know that ‘what works’ in metropolitan areas does not automatically translate to rural and remote areas due to issues of setting and scale,” Professor Mills said.  

“Funding research that goes beyond the remit of hospitals and enables the testing of novel place-based approaches, to rural health and health care in partnership with a wide range of industry partners, must be part of the solution to reducing the inequity gap.”  

It is estimated that only 2.4 per cent of National Health and Medical Research Council funded projects are aimed specifically at improving the health of Australians living in rural and remote areas.  

The La Trobe Rural Health School (LRHS) demonstrates the value of investment in rural health and its meaningful impact on communities. 

The LRHS has used small grants to test new approaches on the delivery of healthcare with a range of industry partners 

In Mildura, La Trobe has partnered with Sunraysia Community Health to transform community health outcomes in various projects, such as extending the reach of place-based research.  

La Trobe is working with McMaster University in Canada as part of a worldwide trial to introduce community paramedicine. In just a short amount of time, the trial has expanded to five different locations and engaged with more than 100 clients 

Dr Hooker, a rural nurse and midwife and LRHS Dean of Research Engagement, said available data from various projects has shown improved patient satisfaction, health outcomes and reduced hospital admissions.  

While these projects have often been funded by small grants, evidence shows they are having a significant, meaningful and lasting impact on communities,” Dr Hooker said.  

“The research partnerships have led to ongoing trusted relationships with industry providers.” 

 Read more about the work of La Trobe's Rural Health School:

The power of AI in boosting rural health care 

New nursing simulation labs for Albury-Wodonga

Ageing on the farm: a John Richards oration

ENDS 


Contact details:

For further information or interviews with Professor Jane Mills, Dr Leesa Hooker or Dr Fiona Burgemeister please contact:

Jess Whitty
Regional Media Advisor 
[email protected]
0481 383 817

 

More from this category

  • Medical Health Aged Care
  • 29/04/2025
  • 00:10
Olon SpA

Olon Group Strengthens Its Leadership in Bioproduction with Two Strategic Appointments in France

MILAN, April 28, 2025 (GLOBE NEWSWIRE) -- Olon Group, a leading global pharmaceutical CDMO, announces the appointment of Jérôme Bédier as CEO of its French entities and Andrea Conforto as M&S VP CDMO of Olon Biotech, the division dedicated to CDMO services for biologics. These appointments reinforce Olon's strategy to expand its capabilities in Antibody-Drug Conjugates (ADCs), Highly Potent Active Pharmaceutical Ingredients (HPAPIs), and microbial bioproduction.An Integrated Vision for ADCs, HPAPIs, and Microbial BioproductionWith this new leadership structure, Olon Group is accelerating the development of its fully integrated ADC offering, covering the entire value chain from Cell Line Development (CLD) to…

  • Medical Health Aged Care
  • 28/04/2025
  • 22:41
Mainstay Medical Holdings plc

Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Anthem Blue Cross/Blue Shield

DUBLIN--BUSINESS WIRE-- Mainstay Medical Holdings plc today announced that Anthem Blue Cross and Blue Shield (“Anthem”) has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. ReActiv8 is the only therapy considered medically necessary by the policy when the conditions for coverage are met. The coverage went into effect on April 16, 2025, and expands access to the procedure, when clinically appropriate, to Anthem’s policyholders. “We have been on a 17-year mission to prove the value of ReActiv8 through careful and thorough research,”said Jason Hannon, CEO of Mainstay Medical.“We have…

  • Medical Health Aged Care
  • 28/04/2025
  • 21:26
Eurosets

Life-saving Technologies at EuroELSO 2025: Eurosets Presents Landing Breathe and Xtreme Rescue

MILAN–BUSINESS WIRE– Eurosets, a cutting-edge Italian company specializing in the design of life-saving medical devices, unveils two crucial innovations at the EuroELSO 2025 congress:…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.